Obesity

Nearly half of adolescents with obesity receiving once-weekly subcutaneous semaglutide achieved overweight or normal weight at 68 weeks, according to data from the STEP TEENS trial presented during the European Congress on Obesity.

A novel glucagon/GLP-1 receptor agonist conferred nearly 15% weight loss at 46 weeks among people with overweight or obesity without type 2 diabetes, according to an industry press release.

For National Women’s Health Week, the Healio Editors compiled news on nutrition of interest to women’s health providers.

Patients with chronic kidney disease and obesity may be at a higher risk for death when experiencing BMI loss at the same time as serum albumin or fat-free mass loss, according to data published in Kidney International Reports.

Obesity may cause DNA damage in the breast tissue of BRCA mutation carriers and may increase breast cancer risk in this already high-risk population, according to multi-institutional research led by investigators at Weill Cornell Medicine.

Survivors of testicular cancer often have undetected risk factors for cardiovascular disease that can lead to worse quality of life, according to data published in Journal of Clinical Oncology.

Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.

A 15-month analysis of conversations regarding pediatric obesity among health care professionals online showed that new clinical guidance from the AAP spurred significant debate.

The prevalence of three pathophysiological traits used to identify patients with sleep apnea differs according to BMI, sex, age and race/ethnicity, according to study results published in Annals of the American Thoracic Society.

CHICAGO — Patients with nonalcoholic fatty liver disease had worse COVID-19-related outcomes compared with infected individuals without NAFLD, according to data presented at Digestive Disease Week.